Dr. Lance Cassell, M.D

NPI: 1205058328
Total Payments
$4,134
2024 Payments
$175.00
Companies
47
Transactions
273
Medicare Patients
2,388
Medicare Billing
$614,169

Payment Breakdown by Category

Food & Beverage$4,107 (99.4%)
Other$19.18 (0.5%)
Education$7.68 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,107 269 99.4%
Entertainment $19.18 1 0.5%
Education $7.68 3 0.2%

Top Paying Companies

Company Total Records Latest Year
Collegium Pharmaceutical, Inc. $726.49 40 $0 (2024)
Daiichi Sankyo Inc. $446.49 50 $0 (2019)
PFIZER INC. $359.34 38 $0 (2021)
Purdue Pharma L.P. $246.98 21 $0 (2018)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $217.86 13 $0 (2022)
Boston Scientific Corporation $165.85 3 $0 (2024)
ASSERTIO THERAPEUTICS, Inc. $160.67 5 $0 (2019)
Kaleo, Inc. $122.85 9 $0 (2019)
PROTEGA PHARMACEUTIALS INC $107.29 5 $0 (2023)
Arbor Pharmaceuticals, Inc. $105.00 7 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $175.00 3 Boston Scientific Corporation ($140.81)
2023 $124.93 7 PROTEGA PHARMACEUTIALS INC ($39.47)
2022 $297.46 13 PROTEGA PHARMACEUTIALS LLC ($67.82)
2021 $205.85 11 Collegium Pharmaceutical, Inc. ($113.82)
2020 $219.25 12 Collegium Pharmaceutical, Inc. ($111.82)
2019 $817.01 59 Collegium Pharmaceutical, Inc. ($142.16)
2018 $1,047 56 Collegium Pharmaceutical, Inc. ($182.99)
2017 $1,247 112 Daiichi Sankyo Inc. ($294.50)

All Payment Transactions

273 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
11/21/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $140.81 General
10/14/2024 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $15.34 General
Category: Opioid Analgesic
05/10/2024 Avanos Medical STANDARD RF DISPOSABLES (Device) Food and Beverage In-kind items and services $18.85 General
Category: PAIN MANAGEMENT
10/09/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $15.64 General
Category: NEUROSCIENCE
10/05/2023 Fidia Pharma USA Inc. HYMOVIS (Device), TRILURON Food and Beverage In-kind items and services $14.66 General
Category: OSTEOARTHRITIS
09/14/2023 Curonix LLC PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) Food and Beverage In-kind items and services $15.23 General
Category: PAIN MANAGEMENT
08/23/2023 Relievant Medsystems, Inc. Intracept (Device), Intracept, Intracept Food and Beverage Cash or cash equivalent $21.54 General
Category: Pain
02/13/2023 Kowa Pharmaceuticals America, Inc. SEGLENTIS (Drug) Food and Beverage In-kind items and services $18.39 General
Category: PAIN MANAGEMENT
01/30/2023 PROTEGA PHARMACEUTIALS INC ROXYBOND (Drug) Food and Beverage In-kind items and services $20.18 General
Category: Pain Management
01/20/2023 PROTEGA PHARMACEUTIALS INC ROXYBOND (Drug) Food and Beverage In-kind items and services $19.29 General
Category: Pain Management
12/12/2022 IBSA Pharma Inc. Tirosint (Drug), Licart, Flector Food and Beverage Cash or cash equivalent $22.89 General
Category: Endocrinology
12/09/2022 PROTEGA PHARMACEUTIALS LLC Roxybond (Drug) Food and Beverage In-kind items and services $21.12 General
Category: Pan Management
10/27/2022 PROTEGA PHARMACEUTIALS LLC Roxybond (Drug) Food and Beverage In-kind items and services $23.35 General
Category: Pan Management
10/22/2022 GRT US Holding, Inc. Qutenza (Drug) Food and Beverage In-kind items and services $56.00 General
Category: Pain Management
10/17/2022 PROTEGA PHARMACEUTIALS LLC Roxybond (Drug) Food and Beverage In-kind items and services $23.35 General
Category: Pan Management
07/11/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $25.30 General
Category: Gastroenterology
06/09/2022 Hikma Pharmaceuticals USA Kloxxado (Drug) Food and Beverage In-kind items and services $12.95 General
Category: Pulmonary/Respiratory Diseases
05/16/2022 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $15.00 General
Category: Opioid Analgesic
04/27/2022 Scilex Pharmaceuticals Inc. Food and Beverage In-kind items and services $24.50 General
04/11/2022 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $20.00 General
Category: Opioid Analgesic
02/16/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $18.33 General
Category: NEUROSCIENCE
02/11/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $13.82 General
Category: NEUROSCIENCE
01/26/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $20.85 General
Category: NEUROSCIENCE
10/20/2021 IBSA Pharma Inc. Licart (Drug) Food and Beverage Cash or cash equivalent $13.93 General
Category: non-opioid analgesic
08/19/2021 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $24.00 General
Category: Opioid Analgesic

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 339 794 $411,070 $61,888
2022 6 611 1,866 $984,909 $168,190
2021 4 704 1,971 $1.0M $179,153
2020 6 734 2,710 $1.5M $204,938
Total Patients
2,388
Total Services
7,341
Medicare Billing
$614,169
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 249 702 $374,810 $56,171 15.0%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 77 77 $30,800 $4,689 15.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 15 $5,460 $1,028 18.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 347 1,594 $852,790 $146,806 17.2%
80307 Testing for presence of drug, by chemistry analyzers Office 2022 156 156 $62,400 $9,493 15.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 31 34 $24,378 $4,837 19.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 23 23 $19,159 $2,693 14.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 28 33 $12,012 $2,226 18.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 26 26 $14,170 $2,136 15.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 402 1,662 $889,170 $155,827 17.5%
80307 Testing for presence of drug, by chemistry analyzers Office 2021 191 194 $77,600 $11,950 15.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 60 60 $49,980 $7,625 15.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 51 55 $20,020 $3,752 18.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 527 2,453 $1.3M $184,498 14.1%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 73 73 $60,809 $9,354 15.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 76 90 $32,760 $4,683 14.3%
62370 Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician Office 2020 13 29 $19,169 $2,295 12.0%
J3490 Unclassified drugs Office 2020 13 33 $16,500 $2,173 13.2%
80307 Testing for presence of drug Office 2020 32 32 $12,800 $1,936 15.1%

About Dr. Lance Cassell, M.D

Dr. Lance Cassell, M.D is a Pain Medicine healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205058328.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Cassell, M.D has received a total of $4,134 in payments from pharmaceutical and medical device companies, with $175.00 received in 2024. These payments were reported across 273 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,107).

As a Medicare-enrolled provider, Cassell has provided services to 2,388 Medicare beneficiaries, totaling 7,341 services with total Medicare billing of $614,169. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.

Practice Information

  • Specialty Pain Medicine
  • Location Sarasota, FL
  • Active Since 05/02/2007
  • Last Updated 04/25/2024
  • Taxonomy Code 2081P2900X
  • Entity Type Individual
  • NPI Number 1205058328

Products in Payments

  • XTAMPZA (Drug) $506.76
  • Movantik (Drug) $256.67
  • Morphabond ER (Drug) $241.04
  • LYRICA (Drug) $240.09
  • RELISTOR ORAL (Drug) $129.98
  • RELISTOR (Drug) $122.62
  • Gralise (Drug) $119.49
  • Xtampza ER (Drug) $110.20
  • Horizant (Drug) $105.00
  • Amitiza (Drug) $104.43
  • Senza Spinal Cord Stimulation System (Device) $86.81
  • PRIALT (Drug) $84.86
  • HYSINGLA ER (Drug) $83.91
  • ARYMO ER (Drug) $81.31
  • XTAMPZAER (Drug) $72.07
  • Roxybond (Drug) $67.82
  • Evzio (Drug) $67.41
  • ZOHYDRO ER (Drug) $64.73
  • Aimovig (Biological) $61.72
  • LUCEMYRA (Drug) $61.34

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Sarasota